Exact Sciences Corporation (NASDAQ:EXAS) Q1 2025 Earnings Call Transcript
Operator: Thank you for standing by. My name is Kate, and I will be your conference operator today.
Exact Sciences Corp (EXAS)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 8,110,000 | $7,158,539 | +146% | 0.06% | |
| 2. | 82,900 | $3,588,741 | -8% | 0.03% | |
| 3. | Leucadia National Ian Cumming And Joseph Steinberg | 67,000 | $2,900,430 | -12% | 0.03% |
| 4. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 59,911 | $2,593,547 | +30% | 1.03% |
| 5. | 1,310,000 | $1,212,474 | -80% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $51.35 | 19,500 | 1,074,191 | 2024-11-13 | Filing | ||
| $37.71 | 2,500 | Director | 60,858 | 2017-08-17 | Filing | |
| $13.84 | 10,000 | Director | 136,379 | 2016-12-14 | Filing | |
| $18.10 | 5,000 | Director | 121,247 | 2016-09-01 | Filing | |
| $17.93 | 3,380 | Director | 105,927 | 2016-08-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $70.00 | 929 | 12,758 | 2024-10-08 | Filing | ||
| $70.00 | 929 | 13,687 | 2024-09-18 | Filing | ||
| $60.15 | 67 | 44,644 | 2024-05-01 | Filing | ||
| $60.15 | 136 | 47,042 | 2024-05-01 | Filing | ||
| $60.15 | 30 | 9,866 | 2024-05-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 17,637,674 | $763,534,908 | 0.01% | |
| 2. | 11,920,721 | $516,047,997 | 0.01% | |
| 3. | 3,281,639 | $142,062,152 | 0.2% | |
| 4. | 2,249,038 | $97,360,855 | 0.27% | |
| 5. | 1,391,599 | $60,242,340 | 0.01% |
News See All
Billionaire George Soros' 10 Small-Cap Stocks with Huge Upside Potential
When a legendary investor like George Soros makes a move, Wall Street pays attention.
12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.
Should You Invest in Exact Sciences Corp. (EXAS)?
Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS)
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Cash-Rich Mid Cap Stocks To Buy Now
Cash flow is the money moving in and out of a business over a set period. It is important because it shows how much cash a company actually has on hand, rather than just looking at profits on paper.
Exact Sciences Corporation (NASDAQ:EXAS) Q4 2024 Earnings Call Transcript
Exact Sciences Corporation (NASDAQ:EXAS) Q4 2024 Earnings Call Transcript February 19, 2025Exact Sciences Corporation misses on earnings expectations.
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Exact Sciences Corporation (EXAS) Rebounded from the Previous Quarter
Columbia Acorn Fund, distributed by Columbia Management Investment Distributors, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Exact Sciences Corporation (NASDAQ:EXAS) Q3 2024 Earnings Call Transcript
Exact Sciences Corporation (NASDAQ:EXAS) Q3 2024 Earnings Call Transcript November 5, 2024Exact Sciences Corporation reports earnings inline with expectations.
Billionaire Hedge Funds
